• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $INBXV

    Inhibrx Inc. Ex-distribution When-Issued

    Subscribe to $INBXV
    $INBXV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Inhibrx Inc. Ex-distribution When-Issued

    DatePrice TargetRatingAnalyst
    See more ratings

    Inhibrx Inc. Ex-distribution When-Issued SEC Filings

    View All

    SEC Form 15-12G filed by Inhibrx Inc. Ex-distribution When-Issued

    15-12G - Inhibrx, Inc. (0001739614) (Filer)

    6/10/24 5:10:27 PM ET
    $INBXV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Inhibrx Inc. Ex-distribution When-Issued Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Viking Global Investors Lp disposed of $214,524,780 worth of shares (7,150,826 units at $30.00) (SEC Form 4)

    4 - Inhibrx, Inc. (0001739614) (Issuer)

    6/3/24 5:55:39 PM ET
    $INBXV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Inhibrx Inc. Ex-distribution When-Issued Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Inhibrx Inc. Ex-distribution When-Issued (Amendment)

    SC 13G/A - Inhibrx, Inc. (0001739614) (Subject)

    6/3/24 5:56:02 PM ET
    $INBXV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care